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RESEARCH ARTICLE
Quality indicators for the diagnosis and antibiotic treatment of acute
respiratory tract infections in general practice: a RAND Appropriateness
Method
Laura Trolle Sausta,b, Lars Bjerrumb, Magnus Arpia and Malene Plejdrup Hansenb,c
aDepartment of Clinical Microbiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark; bSection of General Practice and
Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark; cResearch Unit
for General Practice in Aalborg and Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
ABSTRACT
Objective: To develop quality indicators for the diagnosis and antibiotic treatment of acute
respiratory tract infections, tailored to the Danish general practice setting.
Design: A RAND/UCLA Appropriateness Method was used.
Setting: General practice.
Subjects: A panel of nine experts, mainly general practitioners, was asked to rate the relevance
of 64 quality indicators for the diagnosis and antibiotic treatment of acute respiratory tract
infections based on guidelines. Subsequently, a face-to-face meeting was held to resolve
misinterpretations and to achieve consensus.
Main outcome measures: The experts were asked to rate the indicators on a nine-point Likert
scale. Consensus of appropriateness for a quality indicator was reached if the overall panel
median rating was 7–9 with agreement.
Results: A total of 50 of the 64 proposed quality indicators attained consensus. Consensus was
achieved for 12 indicators focusing on the diagnostic process and 19 indicators focusing on the
decision about antibiotic treatment and choice of antibiotics, respectively.
Conclusion: These newly developed quality indicators may be used to strengthen Danish gen-
eral practitioners’ focus on their management of patients with acute respiratory tract infections
and to identify where there is a need for future quality improvements.
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Background
Worldwide, the increasing rate of antimicrobial resist-
ance (AMR) is a major health problem. AMR is closely
related to the overall consumption of antibiotics [1] as
well as the types of antibiotics consumed [2]. The use
of antibiotics differs between countries: in Europe,
antibiotic prescribing rates are lowest in the Northern
countries, moderate in the Central part, and high in
many Southern countries [1]. Denmark has a relatively
high use of narrow-spectrum penicillins and a very low
consumption of fluoroquinolones, when compared to
many countries in Central and Southern Europe.
However, macrolides are prescribed more often in
Denmark than in other Nordic countries [3]. In the
past 20 years, antibiotic consumption has increased by
40% in Denmark, and in particular, the consumption
of penicillins combined with b-lactamase inhibitors has
increased dramatically [4]. About 90% of antibiotics
are prescribed in primary care with the highest anti-
biotic prescribing rate observed in the Capital Region
[5]. Acute respiratory tract infections (RTIs) are one of
the most common indications for antibiotic prescribing
in general practice [6]. However, the majority of RTIs
are caused by viruses and antibiotic treatment often
provides little benefit, if any [7].
In order to improve the use of antibiotics in general
practice, valid instruments are necessary to identify
potential quality problems of the care provided.
Instruments as quality indicators (QIs) allow bench-
marking by comparisons between practices or coun-
tries and are used to generate a reflection and debate
about the quality of care [8,9]. Preferably, QIs should
be extractable from routine care data. The use of QIs
has proved to be a significant stimulus for the
improvement of antibiotic prescribing [10].
Despite the large number of antibiotic prescriptions
by general practitioners (GPs), only a relatively small
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number of QIs currently exist for infectious diseases in
general practice [11]. Existing QIs mainly focus on the
choice of antibiotics; they are often drug-specific and
fail to encompass the diagnostic process [11].
However, a rational decision about antibiotic prescrib-
ing is based on a proper diagnosis. It is therefore par-
ticularly important that the quality assurance should
be related to a specific diagnosis and should encom-
pass the diagnostic process.
A successful implementation of QIs requires that
GPs find the indicators relevant and suitable for their
daily work in practice. Nevertheless, a recent study
showed that the GPs in Denmark did not find the
existing European QIs suitable for measuring the qual-
ity of antibiotic treatment [12]. During the last 5 years
Danish GPs have been using QIs in their daily work
with different chronic diseases; however, no Danish
QIs for antibiotic prescribing exist.
This study aimed to develop QIs for diagnosis and
antibiotic treatment of RTIs, tailored to the Danish
general practice setting.
Method
A RAND/UCLA Appropriateness Method was used for
the development of the QIs. The RAND/UCLA
Appropriateness Method is a consensus method mainly
used for the development of review criteria for clinical
interventions in U.S.A. [13], although it has also been
used for developing QIs [14]. The method combines the
best available scientific evidence with the collective
judgment of experts, and it has been described as one
of the only thoroughly tested systematic methods com-
bining evidence with expert opinion [15].
The technique consists of various steps [16]:
1. Development of preliminary QIs based on a sys-
tematic literature search.
2. First assessment of the preliminary QIs by experts
using an e-mailed survey.
3. Face-to-face consensus meeting of a panel of
experts.
4. Second assessment of QIs.
Proposals for QIs
A list of 64 preliminary QIs was developed by the
research group (the authors). The QIs were based on
national and international guidelines for the manage-
ment of RTIs [17–19].
The indicators were classified according to the most
frequent diagnoses of infections in primary care
(International Classification of Primary Care, ICPC-2)
[20]: acute tonsillitis, acute otitis media, acute rhinosi-
nusitis, acute bronchitis, pneumonia and acute exacer-
bation of chronic obstructive pulmonary disease
(COPD). The indicators also covered aggregated
groups such as ‘acute RTIs’ and ‘acute lower RTIs’ in
order to assess overall antibiotic prescribing for RTIs.
The QIs were divided into three main groups and
focused on (1) the diagnostic process, (2) the decision
concerning antibiotic treatment and (3) the choice of
antibiotics.
Panel of experts
Experts were purposively sampled and recruited to
ensure that the QIs were valid for routine clinical gen-
eral practice. A nine-person panel was identified with
representation of GPs (n¼ 6), pharmacists (n¼ 1),
infectious disease specialists (n¼ 1) and clinical micro-
biologists (n¼ 1). The final panel of experts consisted
of individuals with solid knowledge and experience in
infectious diseases, treatment with antibiotics and
quality assessment.
Mailed survey
A list of 64 potential QIs was e-mailed to the nine
experts. The experts were asked to rate each indicator
using a nine-point Likert scale ranging from 1 (com-
pletely disagree) through 5 (uncertain) to 9 (com-
pletely agree). Each indicator had to be assessed for
the relevance of measuring the quality of a GP’s man-
agement of patients with RTIs. The indicators either
focused on the quality of (1) the diagnostic process,
(2) the decision concerning antibiotic treatment and
(3) the choice of antibiotics (narrow-spectrum penicil-
lin, amoxicillin ± clavulanic acid, macrolides or quino-
lones). Indicators focusing on the diagnostic process
aim at assessing how correct the given diagnosis is,
i.e. they are assessing if specific criteria are present in
patients with a specific diagnosis.
The experts were provided with evidence-based
guidelines [17,18] and were encouraged to use this
information in their assessment of the QIs. Each indica-
tor was provided with a standard that embodied
acceptability of the particular performance addressed
by that indicator. Low quality of the care provided is
indicated if a performance falls outside the standard
range. The experts were asked to rate each QI with
the provided standard as a complete unit. However, if
the experts disagreed with the standard they were
asked to comment on the disagreement and to rate
the indicator separately. Furthermore, the experts were
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encouraged to propose new QIs or rephrase the
already existing ones.
Face-to-face meeting
A total of seven experts attended the 4-h face-to-face
meeting held in November 2015 in Copenhagen,
Denmark, 10 days after the survey was completed.
Two experts (one GP and one infectious disease spe-
cialist) were unable to attend the meeting and partici-
pated in the process through pre-meeting
conversations and post-meeting rating.
At the meeting, experts were given feedback in the
form of a bar chart showing the distribution of ratings
from the initial round, with the expert’s own rating
marked in the figure.
Only QIs that did not reach consensus in the initial
survey were discussed at the face-to-face meeting. Each
of these indicators were discussed and experts were
encouraged to propose new QIs or rephrase the already
existing ones. The discussion was facilitated by a mod-
erator from the research group (L.T.S.) and evidence-
based literature was cited whenever appropriate.
Finally, the experts were asked to rate these indicators
again at the meeting, i.e. second assessment.
Analysis
For each QI, medians of the Likert scores were calcu-
lated and the indicators were classified into three levels
of appropriateness: (1) appropriate was defined as a
panel median of 7–9 without disagreement, (2) uncer-
tain was defined as a panel median of 4–6 or any
median with disagreement and (3) inappropriate was
defined as a panel median of 1–3 without disagreement.
A classic definition for a nine-member panel, as defined
by the RAND team [16], was used for the definition of
agreement and disagreement. Agreement was defined
as: no more than two experts rated the indicator outside
the three-point region (1–3; 4–6; 7–9) containing the
median. Disagreement was defined as: at least three
experts rate the indicator in the 1–3 region, and at least
three experts rate it in the 7–9 region. Consensus of
appropriateness for an indicator was achieved if the
indicator was classified as appropriate with agreement.
Those indicators with consensus of appropriateness
from either the first or the second round were included
in the final recommended set of indicators.
Results
A total of 39 QIs reached consensus after the initial
assessment. The remaining 25 indicators were
discussed and reassessed at the face-to-face meeting
and another 11 indicators obtained consensus after
the second assessment. Consequently, a total of 50 of
the proposed 64 QIs attained consensus of appropri-
ateness (overall panel median rating of 7–9 with
agreement). Two QIs were rephrased at the meeting,
but no additional indicators were proposed by the
panel of experts.
Consensus of appropriateness was attained for 12
(75%) of the 16 QIs focusing on the diagnostic process
(Table 1). The experts agreed on the use of point-of-
care tests in patients with suspected acute pharyngo-
tonsillitis [rapid Streptococcus A antigen detection
(Strep A) test] fulfilling 2–3 modified Centor criteria,
and in patients with suspected pneumonia [C-reactive
protein rapid (CRP) test]. They also agreed on the diag-
nostic value of examining eardrum mobility in patients
with suspected acute otitis media, as well as taking
into account the duration of symptoms in patients
with suspected acute rhinosinusitis.
Consensus of appropriateness was attained for 19
(70%) of the 27 QIs focusing on the decision to pre-
scribe antibiotics (Table 2). The experts agreed on the
relevance of measuring antibiotic treatment in patients
with acute pharyngotonsillitis with a positive Strep A
test and for systemically unwell patients fulfilling 4–5
modified Centor criteria. The relevance of measuring
prescribing for patients older than 6 onths with acute
otitis media, with no signs of fluid in the middle ear
and <3 days of acute ear pain, was also agreed on.
Consensus of appropriateness was attained for 19
(90%) of the 21 QIs, focusing on the choice of antibiot-
ics (Table 3). The experts agreed on the relevance of
measuring the use of penicillin V for patients with
acute pharyngotonsillitis, acute otitis media, acute rhi-
nosinusitis, acute bronchitis and pneumonia. In gen-
eral, the experts agreed on the relevance of measuring
the use of macrolides for patients without known
penicillin allergy.
No QIs were rated inappropriate with consensus
(overall panel rating of 1–3 with agreement). The 14
QIs not achieving consensus were evenly distributed
between the seven diagnoses. None of the QIs focus-
ing on the proportion of patients treated with a wait-
and-see antibiotic prescription achieved consensus.
Only two QIs focusing on the choice of antibiotics did
not attain consensus. These two indicators measured
the proportion of patients, with either acute rhinosinu-
sitis or acute exacerbation of COPD, treated with
amoxicillin ± clavulanic acid.
Thirty three of the 50 standards were commented
on by some of the experts, and four standards were
changed according to these proposals. For example,
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the proposed standard for patients with acute rhinosi-
nusitis treated with antibiotics was 0–10%, but was
changed to 5–10% according to the experts’ recom-
mendation (Table 2).
Discussion
Main findings
A panel of Danish experts agreed on a total of 50 QIs
for assessing the quality of GPs’ management of
patients with RTIs. The experts agreed on 75% of the
proposed QIs concerning the diagnostic process.
Nearly three quarters of the QIs focusing on the deci-
sion to prescribe antibiotics and almost all QIs focus-
ing on the choice of antibiotics achieved consensus of
appropriateness.
Strengths and limitations
This study adhered to one of the only systematic
methods combining evidence with expert opinion for
developing appropriate scenarios [15,16]. The most
frequently used method for the development of QIs is
the Delphi Method [11], which consists of various pos-
tal rounds of rating. By using the Delphi technique, a
large panel of experts can be included in the process,
but one of the drawbacks is the risk of the experts
becoming fatigued and misinterpretations of the QIs.
The RAND method, exclusively, includes a face-to-face
meeting with the intention to resolve misinterpreta-
tions and improve definitions of QIs [16].
The panel of experts comprised healthcare pro-
viders with solid knowledge about the management of
patients with RTIs and all experts had been involved in
a number of quality improvement activities or relevant
professional organisations. The panel comprised
mainly GPs (six out of nine) as the set of indicators is
aimed at improving GPs’ management of RTIs. Two
experts were unable to participate in the face-to-face
meeting. However, these two experts were provided
with relevant information from the meeting before
being asked to rate the indicators again.
It is of major importance to acknowledge that QIs
only assess easily measurable aspects of care and that
Table 1. QIs focusing on the diagnostic process.
QIs as a ratio (nominator: denominator) Acceptable range (%) Median, range 1–9
Patients with acute pharyngotonsillitis
Number of patients fulfilling 2–3 modified Centor criteria examined with a StrepA
test: number of patients fulfilling 2–3 modified Centor criteria
80–100 9
Number of patients fulfilling 0-1 modified Centor criteria examined with a StrepA
test: number of patients fulfilling 0-1 modified Centor criteria
0–10 9
Number of systemically unwell patients fulfilling 4–5 modified Centor criteria
examined with a StrepA test: number of systemically unwell patients fulfilling 4–5
modified Centor criteria
0–10 3
Patients with acute otitis media
Number of patients >6 months fulfilling one or more diagnostic criteriaa and
reduced mobility of the eardrumb: number of patients >6 months
70–100 8
Number of patients >6 months with an evaluation of the eardrum mobilityb:
number of patients >6 months
70–100 8
Number of patients >6 months with reduced mobility of the eardrumb: number of
patients >6 months
80–100 7
Patients with acute rhinosinusitis
Number of patients with >10 days symptom duration or increasing symptoms after
5 days: number of patients
90–100 9
Number of patients with three or more symptomsc: number of patients 90–100 9
Number of patients examined with a CRP test: number of patients 80–100 2
Patients with acute bronchitis
Number of patients examined with a CRP test: number of patients 20–80 2
Patients with pneumonia
Number of patients fulfilling less than two diagnostic criteriad: number of patients 0–20 9
Number of patients examined with a CRP test: number of patients 80–100 9
Number of patients with a CRP test <20mg/l: number of patients 0–20 8
Number of patients examined with an X-ray of thorax: number of patients 0–30 8
Patients with acute exacerbation of COPD
Number of patients with acute exacerbation of dyspnea, coughing and/or expector-
ation greater than the daily variation: number of patients
90–100 9
Patients whom the doctor suspects have a lower RTI
Number of patients seen on the same day: number of patients 80–100 9
Consensus of appropriateness.
aAcute onset of ear pain, injected eardrum, bulging eardrum.
bEvaluated by tympanometry or pneumatic otoscopy.
cNasal congestion, nasal discharge, pain in the face/teeth, reduced sense of smell, fever.
dSymptoms of lower RTI (cough ± expectoration), emerging findings on examination of the chest (tachypnea, damping and/or auscultation of murmurs),
signs of systemic disease (systemically unwell and/or temperature >38 C).
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they fail to encompass the more complex aspects of
general practice [8]. For example, the severity of an
infection is not always taken into account and this
limitation should be considered when interpreting and
comparing indicators across practices. However, QIs
can be used to generate a reflection about the quality
of care provided and indicate areas in need of quality
improvement.
Table 2. QIs focusing on the decision to prescribe antibiotics.
QIs as a ratio (nominator: denominator) Acceptable range (%) Median, range 1–9
Patients with acute pharyngotonsillitis
Number of patients treated with antibiotics: number of patients 20–40 9
Number of patients with a positive StrepA test treated with antibiotics: number of patients
with a positive StrepA test
90–100 9
Number of patients fulfilling 0–1 modified Centor criterion treated with antibiotics: number of
patients fulfilling 0–1 modified Centor criterion
0–10 9
Number of generally affected patients fulfilling 4–5 modified Centor criteria treated with antibi-
otics: number of generally affected patients fulfilling 4–5 modified Centor criteria
90–100 9
Patients with acute otitis media
Number of patients treated with antibiotics: number of patients 10–50 5
Number of patients <6 months treated with antibiotics: number of patients <6 months 90–100 9
Number of patients >6 months with no signs of fluid in the middle eara treated with antibiot-
ics: number of patients >6 months with no signs of fluid in the middle eara
0–10 9
Number of patients >6 months with 3 days of acute ear pain and no signs of fluid in the
middle eara treated with antibiotics: number of patients >6 months with 3 days of acute
ear pain and no signs of fluid in the middle eara
0–10 9
Number of patients treated with a wait-and-see antibiotic prescription: number of patients
treated with antibiotics
0–30 5
Patients with acute rhinosinusitis
Number of patients treated with antibiotics: number of patients 5–10 9
Number of patients with a CRP test <10mg/l treated with antibiotics: number of patients with
a CRP test <10mg/l
0–10 8
Number of patients fulfilling less than three diagnostic criteriab treated with antibiotics: num-
ber of patients fulfilling less than three diagnostic criteriab
0–10 9
Number of patients fulfilling three or more diagnostic criteriab treated with antibiotics: number
of patients fulfilling three or more diagnostic criteriab
80–100 9
Number of patients with <5 days symptom duration treated with antibiotics: number of
patients with <5 days symptom duration
0–10 9
Number of patients treated with a wait-and-see antibiotic prescription: number of patients
treated with antibiotics
0–30 2
Patients with acute bronchitis
Number of patients treated with antibiotics: number of patients 0–10 9
Number of patients with a CRP test <20mg/l treated with antibiotics: number of patients with
a CRP test <20mg/l
0–10 8
Number of patients with purulent expectorate treated with antibiotics: number of patients
with purulent expectorate
0–10 9
Patients with pneumonia
Number of patients treated with antibiotics: number of patients 90–100 9
Number of patients with a CRP test <20mg/l treated with antibiotics: number of patients with
a CRP test <20mg/l
0–20 3
Number of patients <65 years fulfilling less than diagnostic criteriac treated with antibiotics:
number of patients <65 years fulfilling less than two diagnostic criteriac
0–20 9
Patients with acute exacerbation of COPD
Number of patients treated with antibiotics: number of patients 20–70 5
Number of patients fulfilling 2–3 Anthonisen criteriad treated with antibiotics: number of
patients fulfilling 2–3 Anthonisen criteriad
90–100 9
Patients with acute exacerbation of severe (class C–D) COPD
Number of patients treated with antibiotics: number of patients 80–100 9
Patients with acute exacerbation of mild–moderate (class A–B) COPD
Number of patients with a CRP test <10mg/l and/or absence of fever fulfilling less than two
Anthonisen criteriad treated with antibiotics: number of patients with a CRP test <10mg/l
and/or absence of fever fulfilling less than two Anthonisen criteriad
0–10 9
Patients with acute RTI
Number of patients treated with antibiotics: number of patients 10–30 3
Number of patients prescribed antibiotics by telephone consultation: number of patients
treated with antibiotics
0–10 9
Consensus of appropriateness.
aEvaluated by tympanometry or pneumatic otoscopy and the absence of ear discharge.
bDiscolored nasal discharge and/or purulent secretion in the nasal cavities, strong localised pain, fever (>38 C), elevated CRP, exacerbation after remis-
sion of the disease.
cSymptoms of lower RTI (cough ± expectorate), emerging findings on examination of the chest (tachypnea, damping and/or auscultation of murmurs),
signs of systemic disease (systemically unwell and/or temperature >38 C).
dIncreased dyspnea, increased expectorate, increased purulence of expectorate. If only two criteria are met, one of them is increased purulence of
expectorate.
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Comparison with other studies
The relatively few existing QIs for infectious diseases
mainly consist of drug-specific QIs; only a few other
studies have developed disease-specific QIs [11]. No
clear definition of disease-specific indicators for RTIs
exists. It can be discussed if the criteria for a disease
refer to patients presenting with symptoms and
signs of an infection, or to patients with a registered
diagnosis. We will argue that it depends on the
data source. For example, if data is available through
an electronic database or an audit it will often be
based on ICPC-2 codes, hence it is patients with a
registered diagnosis.
Even the disease-specific QIs often focus on the
choice of antibiotics and fail to encompass the diag-
nostic process [21]. In order to rationalise antibiotic
use, the main focus should be on ‘when to prescribe’.
Hence the majority of the indicators in this study focus
on the diagnostic process and the decision to pre-
scribe antibiotics.
It is of great importance to give careful consider-
ation to the purpose for and setting in which the indi-
cators are planned to be used. In Denmark, there is a
widespread use of point-of-care tests, such as CRP and
Strep A-testing, which can help distinguish self-limiting
infections from more severe ones. Point-of-care tests
Table 3. QIs focusing on the choice of antibiotics.
QIs as a ratio (nominator: denominator) Acceptable range (%) Median, range 1–9
Patients with acute pharyngotonsillitis
Number of patients treated with penicillin V: number of patients treated with
antibiotics
90–100 9
Number of patients with known penicillin allergy treated with macrolides: number of
patients treated with macrolides
90–100 9
Number of patients without known penicillin allergy treated with macrolides: number
of patients treated with macrolides
0–10 9
Patients with acute otitis media
Number of patients treated with penicillin V: number of patients treated with
antibiotics
90–100 9
Number of patients treated with amoxicillin ± clavulanic acid: number of patients
treated with antibiotics
0–20 9
Number of patients with known penicillin allergy treated with macrolides: number of
patients treated with macrolides
90–100 9
Number of patients without known penicillin allergy treated with macrolides: number
of patients treated with macrolides
0–10 9
Patients with acute rhinosinusitis
Number of patients treated with penicillin V: number of patients treated with
antibiotics
90–100 9
Number of patients treated with amoxicillin ± clavulanic acid: number of patients
treated with antibiotics
0–20 9
Number of patients with known penicillin allergy treated with macrolides: number of
patients treated with macrolides
90–100 9
Number of patients without known penicillin allergy treated with macrolides: number
of patients treated with macrolides
0–10 9
Patients with acute bronchitis
Number of patients treated with penicillin V: number of patients treated with
antibiotics
90–100 9
Number of patients treated with amoxicillin ± clavulanic acid: number of patients
treated with antibiotics
0–10 9
Number of patients with known penicillin allergy treated with macrolides: number of
patients treated with macrolides
90–100 9
Number of patients without known penicillin allergy treated with macrolides: number
of patients treated with macrolides
0–10 9
Patients with pneumonia
Number of patients treated with penicillin V: number of patients treated with
antibiotics
80–100 9
Number of patients with known penicillin allergy treated with macrolides: number of
patients treated with macrolides
90–100 9
Number of patients without known penicillin allergy treated with macrolides: number
of patients treated with macrolides
0–10a 9
Patients with acute exacerbation of COPD
Number of patients treated with amoxicillin ± clavulanic acid: number of patients
treated with antibiotics
80–100 8
Number of patients without known penicillin allergy treated with quinolones: number
of patients treated with quinolones
0–10 9
Patients with acute RTI
Number of patients without known penicillin allergy treated with macrolides: number
of patients treated with macrolides
0–10 9
Consensus of appropriateness.
aThis standard cannot be used during a mycoplasma epidemic.
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are not used routinely in primary care in Eastern and
Southern Europe [22]. Hence, in order to investigate
and monitor the quality of antibiotic prescribing in
Denmark, it is important that the QIs are tailored to
the Danish primary healthcare setting. We created 50
QIs tailored to the Danish structure of primary health-
care for use mainly by GPs.
This set of QIs is provided with standards. Simply
knowing the level of an indicator does not show
whether or not it is acceptable. An important final
step to complete the development of an indicator is
to apply a standard, thereby revealing whether or not
the level of the indicator is acceptable [23].
It has previously been demonstrated that clinicians
involved in a specific process, for instance a clinical
activity, tend to rate the quality of the process higher
than those who are not directly involved in the pro-
cess being assessed [24]. In the current study, we
found a similar trend. Thus, the QIs were generally
rated higher by the GPs than by the clinical
microbiologist.
Previous literature has demonstrated that consensus
is more easily achieved for QIs focusing on the choice
of antibiotics than for QIs focusing on the diagnostic
process [25]. Only two QIs focusing on the choice of
antibiotics failed to attain consensus in our study.
These two indicators measured the proportion of
patients, with either acute rhinosinusitis or acute
exacerbation of COPD, who were treated with amoxi-
cillin ± clavulanic acid. In Denmark, the guideline rec-
ommendation for first-line antibiotic treatment of
acute exacerbation of COPD varies between regions.
As the experts represented various geographical
regions it was not possible for them to agree on this
indicator.
Høye et al. [26] have previously demonstrated that
the views of the usefulness of delayed prescribing dif-
fered between GPs. This finding is in line with our
findings, as none of the QIs focusing on the propor-
tion of patients treated with a wait-and-see antibiotic
prescription achieved consensus.
Perspectives
A set of 50 QIs for diagnosis and antibiotic treatment
of RTIs in Danish general practice was developed.
These QIs may be used to strengthen Danish GPs’
focus on their management of patients with RTIs and
to identify where there is a need for future quality
improvements.
This set of QIs is quite large and it would be very
time consuming to apply all 50 indicators at the same
time. However, it is worthwhile choosing just a few of
the indicators, for example all indicators related to a
single diagnosis [27]. This would be valuable if an elec-
tronic administrative data source was available and all
indicators could easily be applied to these data. As for
now, this is not possible in Denmark and we suggest
that GPs or researchers choose a number of these
newly developed indicators and apply them to for
example audit data.
Lack of data, especially details about the diagnostic
process, such as the presence or absence of diagnostic
criteria and the results of point-of-care tests, is often
challenging to the development and implementation
of QIs [28,29]. Although data availability is an import-
ant factor in deciding whether a QI ultimately can be
implemented in general practice, we decided to focus
on the initial question—the relevance of measuring
the quality of care provided. The experts agreed on
data availability as a challenge to the implementation
of indicators, but were asked not to consider this chal-
lenge in the rating process. Our primary purpose was
to develop a measure of quality, regardless of cost
considerations and current opportunities for data
availability.
Danish GPs use IT technology in their daily patient
care, and electronic communication with the health-
care system is well established. Data Capture modules
for chronic diseases are an integrated part of most
computer systems in general practice; automatic data
capture to assess the quality of care is mandatory for
patients with chronic diseases, for example diabetes
and heart failure [30].
The prerequisite for establishing a quality assurance
system for infectious diseases therefore exists. Future
research should focus on the evaluation and applica-
tion of QIs for infectious diseases in order to investi-
gate their relevance for Danish general practice and
reliability in measuring quality of care.
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